Nachrichten zur Amgen Inc. Aktie

Amgen Will Benefit From Increased Medical Spending

…

5 Small Biotech ETFs to Watch (Updated 2024)

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants…

Amgen declares $2.25 Q2 dividend for 2024 By Investing.com

Amgen declares $2.25 Q2 dividend for 2024…

Amgen Inc. (AMGN) Presents at TD Cowen 44th Annual Health Care Conference (Transcript)

…

Amgen: Rating erhöht

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Goldman Sachs stufen die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900, Ticker-Symbol:…

Amgen: A Good Dividend Growth Stock For The Watch List

…

Goldman adds Amgen, Monday.com, Vulcan to Conviction List By Investing.com

Goldman adds Amgen, Monday.com, Vulcan to Conviction List…

Amgen Aktie: Zukunftsträchtiger Ausblick

THOUSAND OAKS, Kalifornien - Amgen, ein Pionier in der Biotechnologie, hat entlang des letzten Jahres beeindruckende 24,3% an Aktienwert zugelegt…

Rare Disease Day 2024: Amgen stellt seltene Erkrankungen in den Fokus

München (ots) - Dieses Jahr fällt der Rare Disease Day auf den 29. Februar. Ein Tag, der den seltenen Erkrankungen…

Better Dividend Growth Stock: AbbVie or Amgen?

A strong case can be made for owning both of these dividend growth stocks. But one of them is the…

Better Dividend Growth Stock: AbbVie or Amgen? @themotleyfool #stocks $ABBV $AMGN $^GSPC

A strong case can be made for owning both of these dividend growth stocks. But one of them is the…

Top Research Reports for NVIDIA, Visa & Amgen

Todays Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Visa Inc. (V) and Amgen…

Aktien USA: Dow Jones heute leicht im Plus (39.165 Pkt.)

Die Aktie von Amgen ist zur Stunde der größte Gewinner im Dow Jones-Index . Das Resultat Das Börsenbarometer klettert um…

Amgen Inc. (AMGN) Amgen Meeting on Rare Disease (Transcript)

…

If You Invested $20,000 in Amgen in 2014, This Is How Much You Would Have Today

Has Amgen been a market-beating stock?…

If You Invested $20,000 in Amgen in 2014, This Is How Much You Would Have Today @themotleyfool #stocks $AMGN

Has Amgen been a market-beating stock?…

Eilt: Big News voraus - Hautkrebs vollständig geheilt. Neuer 312% Biotech Hot Stock nach 31.205% mit Amgen ($AMGN)

London (www.aktiencheck.de, Anzeige) EinschätzungStrong OutperformerKurszieleKursziel 12M: 2,50 EUR Kurschance: 194% Kursziel 24M: 3,50 EUR Kurschance: 312%StammdatenISIN: GB00BM9XQ619 WKN: A3DTUQ Ticker: T9G.HMKursdatenKurs: 0,850 EUR 52W Hoch: 1,630 EUR 52W…

Amgen Inc. (AMGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)

…

The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Amgen, Morphysys and REGENXBIO

Gilead Sciences, Bristol Myers, Amgen, Morphysys and REGENXBIO are included in this Analyst Blog.…

Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable

…

ARWR: Pipeline Reprioritization to Reduce Cash Burn by up to $100 Million This Fiscal Year

By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Pipeline Reprioritization to Cut ~$100 Million in Expenses Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)…

Biotech Stock Roundup: GILD, AMGN & BMYs Q4 Results, MOR Up on NVS Deal & More

Earnings of Gilead (GILD) and Amgen (AMGN) are in focus in the biotech sector.…

Amgen steigert Quartalsgewinn - Kauf von Horizon zahlt sich aus

New York (Reuters) - Die milliardenschwere Übernahme des Biotechunternehmens Horizon Therapeutics zahlt sich für den US-Pharmakonzern Amgen aus.

Das US-Unternehmen steigerte…

Amgen quarterly profit rises 15%, obesity drug trials are on track By Reuters

Amgen steigert Quartalsumsatz kräftig - Fortsetzung im laufenden Jahr erwartet

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hofft nach der Übernahme von Horizon Therapeutics auf einen kräftigen Umsatzanstieg im laufenden…

Amgen steigert Quartalsumsatz kräftig - Fortsetzung im laufenden Jahr erwartet

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen hofft nach der Übernahme von Horizon Therapeutics auf…

Amgen’s quarterly results top expectations despite Enbrel sales decline

Amgen on Tuesday reported fourth quarter profits and sales that topped analyst expectations even as revenues dropped for one of…

Amgen Dips Despite A Record-Breaking Sales Sprint For Nine Drugs

Amgen beat sales and earnings estimates late Tuesday, helped by nine products that hit record sales.…

Amgen Q4 earnings and revenue beat estimates By Investing.com

Amgen Q4 earnings and revenue beat estimates…

Amgen earnings beat by $0.12, revenue topped estimates By Investing.com

Amgen earnings beat by $0.12, revenue topped estimates…

Amgen quarterly profit rises 15% as Horizon deal boosts results

…

Amgen quarterly profit rises 15% as Horizon deal boosts results By Reuters

Amgen quarterly profit rises 15% as Horizon deal boosts results…

DAX höher erwartet, China deutlich im Plus: Infineon, Morphosys, UBS, BP, Linde, Spotify, LVMH, Amgen, Qiagen und Ford im Fokus – das ist heute wichtig

Der DAX hat sich zu Wochenbeginn kaum verändert gezeigt. Letztendlich ging er mit 0,1 Prozent im Minus aus dem Handel…

Amgen’s obesity prospects in focus ahead of Q4 results

…

Merck, Walgreens and Amgen lead way as Dow’s intraday gain hits 200 points

…

Amgen: Debt-Funded Buybacks Constrains Future Gains Per Share

…

Can Amgen (AMGN) Keep the Beat Streak Alive in Q4 Earnings?

Volume growth from Amgens (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially…

Recombinant Proteins Market revenue to hit USD 9 Billion by 2035, says Research Nester

Leading recombinant proteins market players include Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, GenScript Biotech Corporation, AbbVie Inc.,…

The Zacks Analyst Blog Highlights Novartis, Amgen, Palo Alto, Brown & Brown and Ericsson

Novartis, Amgen, Palo Alto, Brown & Brown and Ericsson are included in this Analyst Blog.…

Sarcoma Drugs Industry Review 2018-2023 and Forecast 2024-2028 & 2033: Amgen, Bayer, Eisai, Eli Lilly & Company, and GlaxoSmithKline Dominate the Landscape

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Sarcoma Drugs Global Market Report 2024" report has been added…

Top Research Reports for Novartis, Amgen & Palo Alto Networks

Todays Research Daily features new research reports on 16 major stocks, including Novartis AG (NVS), Amgen Inc. (AMGN) and Palo…

Eilt: Großinvestoren vor Einstieg in innovative Krebstherapie. 182% Biotech Hot Stock nach 31.205% mit Amgen ($AMGN)

London (www.aktiencheck.de, Anzeige) EinschätzungStrong OutperformerKurszieleKursziel 12M: 2,50 EUR Kurschance: 102% Kursziel 24M: 3,50 EUR Kurschance: 182%StammdatenISIN: GB00BM9XQ619 WKN: A3DTUQ Ticker: T9G.HMKursdatenKurs: 1,240 EUR 52W Hoch: 1,630 EUR 52W…

dpa-AFX ProFeed